Kwoon Yong Pok1, Raynal C Squires2, Li Kiang Tan3, Tomohiko Takasaki4, Sazaly Abubakar5, Futoshi Hasebe6, Jeffrey Partridge7, Chin Kei Lee7, Janice Lo8, John Aaskov9, Lee Ching Ng3, Frank Konings7. 1. WHO Collaborating Centre for Reference and Research of Arbovirus and their Associated Vectors, Environmental Health Institute, National Environment Agency, Singapore . ; Both authors contributed equally in the writing of this paper. 2. Emerging Disease Surveillance and Response Unit, Division of Health Security and Emergencies, World Health Organization Regional Office for the Western Pacific, Manila, Philippines . ; Both authors contributed equally in the writing of this paper. 3. WHO Collaborating Centre for Reference and Research of Arbovirus and their Associated Vectors, Environmental Health Institute, National Environment Agency, Singapore . 4. National Institute of Infectious Diseases, Tokyo, Japan . 5. WHO Collaborating Centre for Arbovirus Reference and Research (Dengue/Severe Dengue), Tropical Infectious Diseases Research and Education Centre, Department of Medical Microbiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia . 6. WHO Collaborating Centre for Reference and Research on Tropical and Emerging Virus Diseases, Nagasaki University, Nagasaki, Japan . 7. Emerging Disease Surveillance and Response Unit, Division of Health Security and Emergencies, World Health Organization Regional Office for the Western Pacific, Manila, Philippines . 8. Public Health Laboratory Services Branch, Centre for Health Protection, Department of Health, Hong Kong Special Administrative Region, China . 9. WHO Collaborating Centre for Arbovirus Reference and Research, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Australia .
Abstract
OBJECTIVE: Accurate laboratory testing is a critical component of dengue surveillance and control. The objective of this programme was to assess dengue diagnostic proficiency among national-level public health laboratories in the World Health Organization (WHO) Western Pacific Region. METHODS: Nineteen national-level public health laboratories performed routine dengue diagnostic assays on a proficiency testing panel consisting of two modules: one containing commercial serum samples spiked with cultured dengue viruses for the detection of nucleic acid and non-structural protein 1 (NS1) (Module A) and one containing human serum samples for the detection of anti-dengue virus antibodies (Module B). A review of logistics arrangements was also conducted. RESULTS: All 16 laboratories testing Module A performed reverse transcriptase polymerase chain reaction (RT-PCR) for both RNA and serotype detection. Of these, 15 had correct results for RNA detection and all 16 correctly serotyped the viruses. All nine laboratories performing NS1 antigen detection obtained the correct results. Sixteen of the 18 laboratories using IgM assays in Module B obtained the correct results as did the 13 laboratories that performed IgG assays. Detection of ongoing/recent dengue virus infection by both molecular (RT-PCR) and serological methods (IgM) was available in 15/19 participating laboratories. DISCUSSION: This first round of external quality assessment of dengue diagnostics was successfully conducted in national-level public health laboratories in the WHO Western Pacific Region, revealing good proficiency in both molecular and serological testing. Further comprehensive diagnostic testing for dengue virus and other priority pathogens in the Region will be assessed during future rounds.
OBJECTIVE: Accurate laboratory testing is a critical component of dengue surveillance and control. The objective of this programme was to assess dengue diagnostic proficiency among national-level public health laboratories in the World Health Organization (WHO) Western Pacific Region. METHODS: Nineteen national-level public health laboratories performed routine dengue diagnostic assays on a proficiency testing panel consisting of two modules: one containing commercial serum samples spiked with cultured dengue viruses for the detection of nucleic acid and non-structural protein 1 (NS1) (Module A) and one containing human serum samples for the detection of anti-dengue virus antibodies (Module B). A review of logistics arrangements was also conducted. RESULTS: All 16 laboratories testing Module A performed reverse transcriptase polymerase chain reaction (RT-PCR) for both RNA and serotype detection. Of these, 15 had correct results for RNA detection and all 16 correctly serotyped the viruses. All nine laboratories performing NS1 antigen detection obtained the correct results. Sixteen of the 18 laboratories using IgM assays in Module B obtained the correct results as did the 13 laboratories that performed IgG assays. Detection of ongoing/recent dengue virus infection by both molecular (RT-PCR) and serological methods (IgM) was available in 15/19 participating laboratories. DISCUSSION: This first round of external quality assessment of dengue diagnostics was successfully conducted in national-level public health laboratories in the WHO Western Pacific Region, revealing good proficiency in both molecular and serological testing. Further comprehensive diagnostic testing for dengue virus and other priority pathogens in the Region will be assessed during future rounds.
Authors: Oliver Donoso Mantke; Karin Lemmer; Stefan S Biel; Jan Groen; Herbert Schmitz; Jean Paul Durand; Hervé Zeller; Matthias Niedrig Journal: J Clin Virol Date: 2004-02 Impact factor: 3.168
Authors: Rosanna W Peeling; Harvey Artsob; Jose Luis Pelegrino; Philippe Buchy; Mary J Cardosa; Shamala Devi; Delia A Enria; Jeremy Farrar; Duane J Gubler; Maria G Guzman; Scott B Halstead; Elizabeth Hunsperger; Susie Kliks; Harold S Margolis; Carl M Nathanson; Vinh Chau Nguyen; Nidia Rizzo; Susana Vázquez; Sutee Yoksan Journal: Nat Rev Microbiol Date: 2010-12 Impact factor: 60.633
Authors: Cristina Domingo; Matthias Niedrig; Anette Teichmann; Marco Kaiser; Leonid Rumer; Richard G Jarman; Oliver Donoso-Mantke Journal: PLoS Negl Trop Dis Date: 2010-10-05
Authors: Samir Bhatt; Peter W Gething; Oliver J Brady; Jane P Messina; Andrew W Farlow; Catherine L Moyes; John M Drake; John S Brownstein; Anne G Hoen; Osman Sankoh; Monica F Myers; Dylan B George; Thomas Jaenisch; G R William Wint; Cameron P Simmons; Thomas W Scott; Jeremy J Farrar; Simon I Hay Journal: Nature Date: 2013-04-07 Impact factor: 49.962
Authors: Lucinda E A Johnson; Sarah A Muir-Paulik; Pam Kennedy; Steven Lindstrom; Amanda Balish; Tricia Aden; Ann C Moen Journal: BMC Infect Dis Date: 2015-11-06 Impact factor: 3.090
Authors: Li Ting Soh; Raynal C Squires; Li Kiang Tan; Kwoon Yong Pok; HuiTing Yang; Christina Liew; Aparna Singh Shah; John Aaskov; Sazaly Abubakar; Futoshi Hasabe; Lee Ching Ng; Frank Konings Journal: Western Pac Surveill Response J Date: 2016-04-22
Authors: Mohammad Yazid Abdad; Raynal C Squires; Sebastien Cognat; Christopher John Oxenford; Frank Konings Journal: Western Pac Surveill Response J Date: 2017-09-29